{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifebmgztlocu7mp2smj2co5nujasyb36fnaxrh2zekklam7eafcdi",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mevv4imudzc2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiajjfhmw4dfmzy2hk4leytb2a37bum5pa4x4x67e4blnqidhwkbni"
    },
    "mimeType": "image/jpeg",
    "size": 712489
  },
  "path": "/news/2026-02-obesity-glp-1s.html",
  "publishedAt": "2026-02-15T09:00:05.000Z",
  "site": "https://medicalxpress.com",
  "tags": [
    "Overweight & Obesity"
  ],
  "textContent": "By 2030, nearly half of all American adults will have obesity, according to research published in the New England Journal of Medicine. In every single state, researchers expect at least 35% of adults to have a body mass index of 30 or higher, the threshold that defines obesity. That prediction may come as a shock, as weight loss medications like Wegovy and Zepbound become more popular and more affordable.",
  "title": "Obesity rates are rising, despite GLP-1s. What does it mean?"
}